RÉSUMÉ
Since November 2023, the absolute number of attendances at emergency departments for pneumonia among children aged 5-14 years in England have been above expected levels for the time of year. This increased signal peaked during March 2024 but then persisted into early summer 2024 despite decreases in prevalence of seasonal respiratory pathogens. Record linkage between emergency department and laboratory databases points to this unusual activity being driven largely by Mycoplasma pneumoniae.
Sujet(s)
Service hospitalier d'urgences , Mycoplasma pneumoniae , Pneumopathie infectieuse , Humains , Enfant , Angleterre/épidémiologie , Enfant d'âge préscolaire , Adolescent , Incidence , Pneumopathie infectieuse/épidémiologie , Mâle , Femelle , Mycoplasma pneumoniae/isolement et purification , Service hospitalier d'urgences/statistiques et données numériques , Prévalence , Pneumopathie à mycoplasmes/épidémiologie , Pneumopathie à mycoplasmes/diagnostic , Saisons , Surveillance de la populationRÉSUMÉ
OBJECTIVES: Inappropriate prescribing of antibiotics is a key driver of antimicrobial resistance. This study aimed to describe urine sampling rates and antibiotic prescribing for patients with lower urinary tract infections (UTIs) in English general practice. DESIGN: A retrospective population-based study using administrative data. SETTING: IQVIA Medical Research Database (IMRD) data from general practices in England, 2015-2022. PARTICIPANTS: Patients who have consulted with an uncomplicated UTI in England general practices captured in the IMRD. OUTCOME MEASURES: Trends in UTI episodes (episodes were defined as UTI diagnosis codes occurring within 14 days of each other), testing and antibiotic prescribing on the same day as initial UTI consultation were assessed from January 2015 to December 2022. Associations, using univariate and multivariate logistic regressions, were examined between consultation and demographic factors on the odds of a urine test. RESULTS: There were 743 350 UTI episodes; 50.8% had a urine test. Testing rates fluctuated with an upward trend and large decline in 2020. Same-day UTI antibiotic prescribing occurred in 78.2% of episodes. In multivariate modelling, factors found to decrease odds of a urine test included age ≥85 years (0.83, 95% CI 0.82 to 0.84), consultation type (remote vs face to face, 0.45, 95% CI 0.45 to 0.46), episodes in London compared with the South (0.74, 95% CI 0.72 to 0.75) and increasing practice size (0.77, 95% CI 0.76 to 0.78). Odds of urine tests increased in males (OR 1.11, 95% CI 1.10 to 1.13), for those episodes without a same-day UTI antibiotic (1.10, 95% CI 1.04 to 1.16) for episodes for those with higher deprivation status (Indices of Multiple Deprivation 8 vs 1, 1.51, 95% CI 1.48 to 1.54). Compared with 2015, 2016-2019 saw increased odds of testing while 2020 and 2021 saw decreases, with 2022 showing increased odds. CONCLUSION: Urine testing for UTI in general practice in England showed an upward trend, with same-day antibiotic prescribing remaining consistent, suggesting greater alignment to national guidelines. The COVID-19 pandemic impacted testing rates, though as of 2022, they began to recover.
Sujet(s)
Antibactériens , Médecine générale , Types de pratiques des médecins , Examen des urines , Infections urinaires , Humains , Angleterre/épidémiologie , Infections urinaires/diagnostic , Infections urinaires/traitement médicamenteux , Infections urinaires/urine , Infections urinaires/épidémiologie , Mâle , Femelle , Études rétrospectives , Médecine générale/tendances , Antibactériens/usage thérapeutique , Adulte d'âge moyen , Sujet âgé , Examen des urines/méthodes , Types de pratiques des médecins/tendances , Types de pratiques des médecins/statistiques et données numériques , Sujet âgé de 80 ans ou plus , Adulte , Prescription inappropriée/statistiques et données numériques , Adolescent , Jeune adulte , Modèles logistiquesRÉSUMÉ
We describe an outbreak of Ralstonia pickettii in the United Kingdom, with isolates genetically indistinguishable from a 2023 Australian outbreak linked to internationally distributed saline solutions. Confirmed cases (n = 3) had bacteraemia, clinically relevant infection, indwelling venous lines and frequent healthcare contact. Multi-stakeholder intervention was required including product recall and risk communications. We recommend a low threshold for investigating clusters of Ralstonia species and similar opportunistic pathogens, considering contaminated product sources. Effective mitigation requires multi-agency partnership and international collaboration.
Sujet(s)
Épidémies de maladies , Infections bactériennes à Gram négatif , Ralstonia pickettii , Humains , Royaume-Uni/épidémiologie , Ralstonia pickettii/isolement et purification , Ralstonia pickettii/génétique , Infections bactériennes à Gram négatif/épidémiologie , Infections bactériennes à Gram négatif/microbiologie , Solution physiologique salée , Bactériémie/épidémiologie , Bactériémie/microbiologie , Australie/épidémiologie , Contamination de médicament , MâleRÉSUMÉ
Existing models for estimating pesticide bioconcentration in earthworms exhibit limited applicability across different chemicals, soils and species which restricts their potential as an alternative, intermediate tier for risk assessment. We used experimental data from uptake and elimination studies using three earthworm species (Lumbricus terrestris, Aporrectodea caliginosa, Eisenia fetida), five pesticides (log Kow 1.69-6.63) and five soils (organic matter content = 0.972-39.9 wt %) to produce a first-order kinetic accumulation model. Model applicability was evaluated against a data set of 402 internal earthworm concentrations reported from the literature including chemical and soil properties outside the data range used to produce the model. Our models accurately predict body load using either porewater or bulk soil concentrations, with at least 93.5 and 84.3% of body load predictions within a factor of 10 and 5 of corresponding observed values, respectively. This suggests that there is no need to distinguish between porewater and soil exposure routes or to consider different uptake and elimination pathways when predicting earthworm bioconcentration. Our new model not only outperformed existing models in characterizing earthworm exposure to pesticides in soil, but it could also be integrated with models that account for earthworm movement and fluctuating soil pesticide concentrations due to degradation and transport.
Sujet(s)
Oligochaeta , Pesticides , Polluants du sol , Sol , Animaux , Oligochaeta/métabolisme , Pesticides/métabolisme , Sol/composition chimique , Polluants du sol/métabolisme , CinétiqueRÉSUMÉ
In this study, we assessed the impact of commercially available polymyxin B against VRP-034 (novel formulation of polymyxin B) using a validated in vitro human renal model, aProximateTM. Freshly isolated primary proximal tubule cells (PTCs) were cultured in Transwell plates and treated with various concentrations of the formulations for up to 48 h. The functional expression of megalin-cubilin receptors in PTC monolayers was validated using FITC-conjugated albumin uptake assays. Polymyxin B and VRP-034 were evaluated at six concentrations (0.3, 1, 3, 10, 30, and 60 µM), and nephrotoxicity was assessed through measurements of transepithelial electrical resistance (TEER), intracellular adenosine triphosphate (ATP) levels, lactate dehydrogenase (LDH) release, and novel injury biomarkers [kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and clusterin]. Additionally, histological analysis using annexin V apoptosis staining was performed. Our results indicated a significant decrease in TEER with polymyxin B at concentrations ≥10 µM compared to VRP-034. Toxic effects were observed from ATP and LDH release only at concentrations ≥30 µM for both formulations. Furthermore, injury biomarker release was higher with polymyxin B compared to VRP-034, particularly at concentrations ≥10 µM. Histologically, polymyxin B-treated PTCs showed increased apoptosis compared to VRP-034-treated cells. Overall, VRP-034 demonstrated improved tolerance in the aProximateTM model compared to polymyxin B, suggesting its potential as a safer alternative for renal protection.
Sujet(s)
Antibactériens , Infections à staphylocoques , Vancomycine , Humains , Études rétrospectives , Infections à staphylocoques/traitement médicamenteux , Infections à staphylocoques/microbiologie , Nouveau-né , Antibactériens/usage thérapeutique , Vancomycine/usage thérapeutique , Femelle , Mâle , Soins intensifs néonatals , Unités de soins intensifs néonatals , Staphylococcus aureus/effets des médicaments et des substances chimiques , Tests de sensibilité microbienneRÉSUMÉ
Antimicrobial resistance (AMR) poses serious challenges to the healthcare systems worldwide. Multiple factors and activities contribute to the development and spread of antimicrobial-resistant microorganisms. Monitoring progress in combating AMR is fundamental at both global and national levels to drive multisectoral actions, identify priorities, and coordinate strategies. Since 2017, the World Health Organization (WHO) has collected data through the Tracking AMR Country Self-Assessment Survey (TrACSS). TrACSS data are published in a publicly-available database. In 2023, 71 (59.9%) out of 177 responding countries reported the existence of a monitoring and evaluation plan for their National Action Plan (NAP) on AMR, and just 20 countries (11.3%) the allocation of funding to support NAP implementation. Countries reported challenges including limited financial and human resources, lack of technical capacity, and variable political commitment. Even across the Group of Seven (G7) countries, which represent some of the world's most advanced economies, many areas still need improvement, such as full implementation of infection prevention and control measures, adoption of WHO access/watch/reserve (AWaRe) classification of antibiotics, effective integration of laboratories in AMR surveillance in the animal health and food safety sectors, training and education, good manufacturing and hygiene practices in food processing, optimising pesticides use and environmental residues of antimicrobial drugs. Continuous and coordinated efforts are needed to strengthen multisectoral engagement to fight AMR.
Sujet(s)
Organisation mondiale de la santé , Humains , Enquêtes et questionnaires , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Résistance bactérienne aux médicaments , Auto-évaluation (psychologie) , Santé mondiale , AnimauxRÉSUMÉ
The emergent fungal pathogen Candida auris is increasingly recognised as an important cause of healthcare-associated infections globally. It is highly transmissible, adaptable, and persistent, resulting in an organism with significant outbreak potential that risks devastating consequences. Progress in the ability to identify C. auris in clinical specimens is encouraging, but laboratory diagnostic capacity and surveillance systems are lacking in many countries. Intrinsic resistance to commonly used antifungals, combined with the ability to rapidly acquire resistance to therapy, substantially restricts treatment options and novel agents are desperately needed. Despite this, outbreaks can be interrupted, and mortality avoided or minimised, through the application of rigorous infection prevention and control measures with an increasing evidence base. This review provides an update on epidemiology, the impact of the COVID-19 pandemic, risk factors, identification and typing, resistance profiles, treatment, detection of colonisation, and infection prevention and control measures for C. auris. This review has informed a planned 2024 update to the United Kingdom Health Security Agency (UKHSA) guidance on the laboratory investigation, management, and infection prevention and control of Candida auris. A multidisciplinary response is needed to control C. auris transmission in a healthcare setting and should emphasise outbreak preparedness and response, rapid contact tracing and isolation or cohorting of patients and staff, strict hand hygiene and other infection prevention and control measures, dedicated or single-use equipment, appropriate disinfection, and effective communication concerning patient transfers and discharge.
Sujet(s)
Antifongiques , COVID-19 , Candida auris , Candidose , Prévention des infections , Humains , Candidose/prévention et contrôle , Candidose/épidémiologie , Candidose/traitement médicamenteux , Candidose/microbiologie , Prévention des infections/méthodes , Candida auris/effets des médicaments et des substances chimiques , COVID-19/prévention et contrôle , COVID-19/épidémiologie , Antifongiques/usage thérapeutique , Antifongiques/pharmacologie , Angleterre/épidémiologie , Infection croisée/prévention et contrôle , Infection croisée/épidémiologie , Infection croisée/microbiologie , SARS-CoV-2 , Résistance des champignons aux médicaments , Candida/effets des médicaments et des substances chimiques , Candida/classification , Candida/isolement et purification , Épidémies de maladies/prévention et contrôleRÉSUMÉ
The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1UK to be the dominant source of invasive infections in this upsurge. Compared with ancestral M1global strains, invasive M1UK strains exhibit reduced genomic diversity and fewer mutations in two-component regulator genes covRS. The emergence of M1UK is dated to 2008. Following a bottleneck coinciding with the COVID-19 pandemic, three emergent M1UK clades underwent rapid nationwide expansion, despite lack of detection in previous years. All M1UK isolates thus-far sequenced globally have a phylogenetic origin in the UK, with dispersal of the new clades in Europe. While waning immunity may promote streptococcal epidemics, the genetic features of M1UK point to a fitness advantage in pathogenicity, and a striking ability to persist through population bottlenecks.
Sujet(s)
COVID-19 , Phylogenèse , Infections à streptocoques , Streptococcus pyogenes , Streptococcus pyogenes/génétique , Streptococcus pyogenes/pathogénicité , Streptococcus pyogenes/isolement et purification , Royaume-Uni/épidémiologie , Humains , Infections à streptocoques/épidémiologie , Infections à streptocoques/microbiologie , COVID-19/épidémiologie , Pandémies , Scarlatine/épidémiologie , Scarlatine/microbiologie , Mutation , Protéines de répression/génétique , SARS-CoV-2/génétique , SARS-CoV-2/isolement et purification , Génome bactérien , Europe/épidémiologie , Protéines bactériennesRÉSUMÉ
HYDRUS 2D was used to simulate chloropicrin (CP) emissions across a range of expected application and environmental conditions present within California, where CP is widely used in the pre-plant treatment of soils for high-value specialty crops. Simulations were developed based on field calibration work and physicochemical parameters from literature with additional consideration of application rate-dependent degradation and applicator practices including application depth, application mode, and tarp material. Model output was compared to the distribution of indirect whole-field flux estimates derived from field monitoring studies using measures of maximum 8-h, maximum 24-h, and cumulative emissions due to their relevance to public health. We observed a strong linear relationship (R2 ≥ 0.80, p < 0.001) between HYDRUS-simulated and field-based maximum flux estimates and no evidence of statistical difference depending on the estimation source for maximum 24-h flux. A linear relationship of similar strength (R2 = 0.82, p < 0.001) was observed between simulated and field-based cumulative emission estimates, although mean HYDRUS estimates were lower than field-estimated values for some high-emission application methods. Analysis of simulation output demonstrated large differences in CP emissions in response to application method and a non-linear increase in CP emissions with increasing application rate, with considerable interaction between application variables including application depth, tarp types, and field layout. The findings generally support the use of simulated CP emission estimates as a tool to address gaps in field-based flux estimates, particularly where characterization of short-term peak emissions is needed.
RÉSUMÉ
PURPOSE: Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection. The purpose of the study was to measure the associations of specific exposures (deprivation, ethnicity, and clinical characteristics) with incident sepsis and case fatality. METHODS: Two research databases in England were used including anonymized patient-level records from primary care linked to hospital admission, death certificate, and small-area deprivation. Sepsis cases aged 65-100 years were matched to up to six controls. Predictors for sepsis (including 60 clinical conditions) were evaluated using logistic and random forest models; case fatality rates were analyzed using logistic models. RESULTS: 108,317 community-acquired sepsis cases were analyzed. Severe frailty was strongly associated with the risk of developing sepsis (crude odds ratio [OR] 14.93; 95% confidence interval [CI] 14.37-15.52). The quintile with most deprived patients showed an increased sepsis risk (crude OR 1.48; 95% CI 1.45-1.51) compared to least deprived quintile. Strong predictors for sepsis included antibiotic exposure in prior 2 months, being house bound, having cancer, learning disability, and diabetes mellitus. Severely frail patients had a case fatality rate of 42.0% compared to 24.0% in non-frail patients (adjusted OR 1.53; 95% CI 1.41-1.65). Sepsis cases with recent prior antibiotic exposure died less frequently compared to non-users (adjusted OR 0.7; 95% CI 0.72-0.76). Case fatality strongly decreased over calendar time. CONCLUSION: Given the variety of predictors and their level of associations for developing sepsis, there is a need for prediction models for risk of developing sepsis that can help to target preventative antibiotic therapy.
Sujet(s)
Soins de santé primaires , Sepsie , Humains , Sepsie/mortalité , Sepsie/épidémiologie , Sujet âgé , Angleterre/épidémiologie , Mâle , Femelle , Études cas-témoins , Sujet âgé de 80 ans ou plus , Soins de santé primaires/statistiques et données numériques , Facteurs de risque , Ethnies/statistiques et données numériques , Hospitalisation/statistiques et données numériques , Hôpitaux/statistiques et données numériques , Infections communautaires/mortalité , Infections communautaires/épidémiologieSujet(s)
Récidive , Amygdalectomie , Amygdalite , Humains , Amygdalite/chirurgie , Enfant , Résultat thérapeutiqueRÉSUMÉ
CASE: A 24-year-old man with Klippel-Trenaunay syndrome (KTS) presented with severe knee osteoarthritis unresponsive to conservative measures. Owing to end-stage, debilitating arthritic symptoms, surgery was pursued. Careful preoperative, multidisciplinary planning/treatment included magnetic resonance imaging to characterize the venous malformations throughout the right lower extremity, preoperative sclerotherapy, sirolimus, and robotic-assisted cementless total knee arthroplasty (TKA). CONCLUSION: Cementless robotic-assisted TKA with selective patellar resurfacing can be a viable option for young KTS patients with severe osteoarthritis when a meticulous multidisciplinary approach, including sclerotherapy and advanced imaging, is undertaken to analyze vascular abnormalities, minimize surgical risks, preserve bone stock, and optimize outcomes.
Sujet(s)
Arthroplastie prothétique de genou , Syndrome de Klippel-Trénaunay , Gonarthrose , Interventions chirurgicales robotisées , Mâle , Humains , Jeune adulte , Adulte , Syndrome de Klippel-Trénaunay/complications , JambeRÉSUMÉ
Modelling approaches to estimate the bioaccumulation of organic chemicals by earthworms are important for improving the realism in risk assessment of chemicals. However, the applicability of existing models is uncertain, partly due to the lack of independent datasets to test them. This study therefore conducted a comprehensive literature review on existing empirical and kinetic models that estimate the bioaccumulation of organic chemicals in earthworms and gathered two independent datasets from published literature to evaluate the predictive performance of these models. The Belfroid et al. (1995a) model is the best-performing empirical model, with 91.2% of earthworm body residue simulations within an order of magnitude of observation. However, this model is limited to the more hydrophobic pesticides and to the earthworm species Eisenia fetida or Eisenia andrei. The kinetic model proposed by Jager et al. (2003b) which out-performs that of Armitage and Gobas (2007), predicted uptake of PCB 153 in the earthworm E. andrei to within a factor of 10. However, the applicability of Jager et al.'s model to other organic compounds and other earthworm species is unknown due to the limited evaluation dataset. The model needs to be parameterised for different chemical, soil, and species types prior to use, which restricts its applicability to risk assessment on a broad scale. Both the empirical and kinetic models leave room for improvement in their ability to reliably predict bioaccumulation in earthworms. Whether they are fit for purpose in environmental risk assessment needs careful consideration on a case by case basis.
Sujet(s)
Oligochaeta , Pesticides , Polluants du sol , Animaux , Polluants du sol/analyse , Bioaccumulation , Composés chimiques organiques , Sol/composition chimiqueRÉSUMÉ
Modern deep learning training procedures rely on model regularization techniques such as data augmentation methods, which generate training samples that increase the diversity of data and richness of label information. A popular recent method, mixup, uses convex combinations of pairs of original samples to generate new samples. However, as we show in our experiments, mixup can produce undesirable synthetic samples, where the data is sampled off the manifold and can contain incorrect labels. We propose ζ-mixup, a generalization of mixup with provably and demonstrably desirable properties that allows convex combinations of T≥2 samples, leading to more realistic and diverse outputs that incorporate information from T original samples by using a p-series interpolant. We show that, compared to mixup, ζ-mixup better preserves the intrinsic dimensionality of the original datasets, which is a desirable property for training generalizable models. Furthermore, we show that our implementation of ζ-mixup is faster than mixup, and extensive evaluation on controlled synthetic and 26 diverse real-world natural and medical image classification datasets shows that ζ-mixup outperforms mixup, CutMix, and traditional data augmentation techniques. The code will be released at https://github.com/kakumarabhishek/zeta-mixup.
RÉSUMÉ
BACKGROUND: People who inject drugs (PWID) are at increased risk of community-acquired Staphylococcus aureus bacteremia (CA-SAB), but little is known about clinical outcomes of CA-SAB in PWID compared with the wider population of patients with CA-SAB. METHODS: Three national datasets were linked to provide clinical and mortality data on patients hospitalized with CA-SAB in England between 1 January 2017 and 31 December 2020. PWID were identified using the International Classification of Diseases, Tenth Revision code for "mental health and behavioral disorder due to opioid use" (F11). Multivariable logistic regression was used to estimate adjusted odds ratios (aORs) for associations of PWID with 30-day all-cause mortality and 90-day hospital readmission. RESULTS: In 10 045 cases of CA-SAB, 1612 (16.0%) were PWID. Overall, 796 (7.9%) patients died within 30 days of CA-SAB admission and 1189 (11.8%) patients were readmitted to hospital within 90 days of CA-SAB. In those without infective endocarditis, there was strong evidence of lower odds of mortality among PWID compared with non-PWID (aOR, 0.47 [95% confidence interval {CI}: .33-.68]; P < .001), whereas there was no association in CA-SAB case fatality with endocarditis (aOR, 1.40 [95% CI: .87-2.25]; P = .163). PWID were less likely to be readmitted within 90 days of CA-SAB (aOR, 0.79 [95% CI: .65-.95]; P = .011). CONCLUSIONS: In this large cohort study of patients with CA-SAB in England, PWID had lower odds of death in the absence of endocarditis and lower odds of readmission within 90 days compared to non-PWID patients. This study highlights the overrepresentation of PWID among patients with CA-SAB nationally.
Sujet(s)
Bactériémie , Infections communautaires , Infections à staphylocoques , Staphylococcus aureus , Toxicomanie intraveineuse , Humains , Mâle , Infections à staphylocoques/épidémiologie , Infections à staphylocoques/mortalité , Femelle , Angleterre/épidémiologie , Bactériémie/épidémiologie , Bactériémie/mortalité , Adulte , Adulte d'âge moyen , Toxicomanie intraveineuse/complications , Toxicomanie intraveineuse/épidémiologie , Infections communautaires/épidémiologie , Infections communautaires/microbiologie , Infections communautaires/mortalité , Études de cohortes , Réadmission du patient/statistiques et données numériques , Sujet âgé , Jeune adulte , Facteurs de risqueRÉSUMÉ
BACKGROUND AND AIMS: Sepsis is a serious and life-threatening condition caused by a dysregulated immune response to an infection. Recent guidance issued in the UK gave recommendations around recognition and antibiotic treatment of sepsis, but did not consider factors relating to health inequalities. The aim of this study was to summarise the literature investigating associations between health inequalities and sepsis. METHODS: Searches were conducted in Embase for peer-reviewed articles published since 2010 that included sepsis in combination with one of the following five areas: socioeconomic status, race/ethnicity, community factors, medical needs and pregnancy/maternity. RESULTS: Five searches identified 1,402 studies, with 50 unique studies included in the review after screening (13 sociodemographic, 14 race/ethnicity, 3 community, 3 care/medical needs and 20 pregnancy/maternity; 3 papers examined multiple health inequalities). Most of the studies were conducted in the USA (31/50), with only four studies using UK data (all pregnancy related). Socioeconomic factors associated with increased sepsis incidence included lower socioeconomic status, unemployment and lower education level, although findings were not consistent across studies. For ethnicity, mixed results were reported. Living in a medically underserved area or being resident in a nursing home increased risk of sepsis. Mortality rates after sepsis were found to be higher in people living in rural areas or in those discharged to skilled nursing facilities while associations with ethnicity were mixed. Complications during delivery, caesarean-section delivery, increased deprivation and black and other ethnic minority race were associated with post-partum sepsis. CONCLUSION: There are clear correlations between sepsis morbidity and mortality and the presence of factors associated with health inequalities. To inform local guidance and drive public health measures, there is a need for studies conducted across more diverse setting and countries.
Sujet(s)
Sepsie , Humains , Facteurs de risque , Femelle , Grossesse , Facteurs socioéconomiques , Ethnies , Inégalités en matière de santé , Disparités de l'état de santéRÉSUMÉ
In 2022, there were global reports of increased numbers of acute hepatitis not explained by hepatitis A-E virus infection in children. This manuscript summarises histopathology results from 20 patients in the United Kingdom who underwent liver transplant or had a liver biopsy as part of aetiological investigations. All available histopathological samples were reviewed centrally as part of the outbreak investigation. A working group comprised of infection specialists, hepatologists and histopathologists met virtually to review the cases, presentation, investigations and histopathology. All 20 liver samples had evidence of inflammation without significant interface activity, and submassive confluent pan-lobular or multilobular hepatocellular necrosis. Overall, the predominant histopathological findings were of acute nonspecific hepatitis with submassive hepatic necrosis and central vein perivenulitis and endothelitis. Histopathological findings were a poor indicator of aetiology.
Sujet(s)
Hépatite , Maladies du foie , Transplantation hépatique , Humains , Enfant , Foie/anatomopathologie , Hépatite/anatomopathologie , Maladies du foie/anatomopathologie , BiopsieRÉSUMÉ
The uptake and elimination kinetics of pesticides from soil to earthworms are important in characterising the risk of pesticides to soil organisms and the risk from secondary poisoning. However, the understanding of the relative importance of chemical, soil, and species differences in determining pesticide bioconcentration into earthworms is limited. Furthermore, there is insufficient independent data in the literature to fully evaluate existing predictive bioconcentration models. We conducted kinetic uptake and elimination experiments for three contrasting earthworm species (Lumbricus terrestris, Aporrectodea caliginosa, Eisenia fetida) in five soils using a mixture of five pesticides (log Kow 1.69 - 6.63). Bioconcentration increased with pesticide hydrophobicity and decreased with soil organic matter. Bioconcentration factors were comparable between earthworm species for hydrophilic pesticides due to the similar water content of earthworm species. Inter-species variations in bioconcentration of hydrophobic pesticides were primarily accounted for by earthworm lipid content and specific surface area (SSA). Existing bioconcentration models either failed to perform well across earthworm species and for more hydrophilic compounds (log Kow < 2) or were not parameterised for a wide range of compounds and earthworm species. Refined models should incorporate earthworm properties (lipid content and SSA) to account for inter-species differences in pesticide uptake from soil.